Di Lorenzo G, Di Maio M, Buonerba C. Neoadjuvant Therapy in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer: Recent Progress, Challenges, and Future Directions in the Era of TAR-200 and Enfortumab Vedotin Plus Pembrolizumab. Oncol Ther 2026 Feb 21. doi: 10.1007/s40487-026-00417.
PMID: 41722015